Skip to content

Phenylketonuria (NORD)





Population genetics
Genetic disorders
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Beckwith-Wiedemann syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Polycystic kidney disease
Familial adenomatous polyposis
Familial hypercholesterolemia
Hereditary spherocytosis
Huntington disease
Li-Fraumeni syndrome
Marfan syndrome
Multiple endocrine neoplasia
Myotonic dystrophy
Treacher Collins syndrome
Tuberous sclerosis
von Hippel-Lindau disease
Polycystic kidney disease
Cystic fibrosis
Friedreich ataxia
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Krabbe disease
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Primary ciliary dyskinesia
Phenylketonuria (NORD)
Sickle cell disease (NORD)
Tay-Sachs disease (NORD)
Wilson disease
Fragile X syndrome
Alport syndrome
X-linked agammaglobulinemia
Fabry disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Lesch-Nyhan syndrome
Muscular dystrophy
Ornithine transcarbamylase deficiency
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review

Phenylketonuria (NORD)


0 / 12 complete


0 / 4 complete
High Yield Notes
7 pages

Phenylketonuria (NORD)

12 flashcards

USMLE® Step 1 style questions USMLE

4 questions

A 22-year-old primigravida at 26 weeks gestation comes to the office for routine prenatal care. The patient reports good fetal movement and has no complaints. She has been inconsistent with prenatal care following her initial visit at 12 weeks. An ultrasound for gestational dating at the time was consistent with her last menstrual period. The mother’s blood group is B-negative while the father’s is O-negative. The patient’s past medical history is significant for phenylketonuria. Prior to conceiving, she followed a phenylalanine-restricted diet. Temperature is 37.0°C (98.6°F), pulse is 92/min, respirations are 20/min, and blood pressure is 105/75 mmHg. An ultrasound reveals a fetus at 26 weeks with an estimated weight <10 percentile for gestational age. Laboratory evaluation reveals elevated phenylalanine levels. Which of the following pathologies is the fetus likely to suffer from based on the maternal history? 

External References

Content Reviewers:

Rishi Desai, MD, MPH

In Phenylketonuria, “Phenylketone" is a product of the amino acid phenylalanine, and “uria” means a substance present in urine. So people with phenylketonuria have phenylketones in their urine, and they develop symptoms like intellectual disability, psychiatric disorders, and seizures.

Now, amino acids are the basic building blocks that make up proteins. Phenylalanine is one of the essential amino acids, meaning our bodies can't make but must be acquired through food that contains protein. Since the body can’t store amino acids, any excess amino acids are converted into glucose or ketones and used for energy.

Phenylalanine is converted to tyrosine by phenylalanine hydroxylase enzyme, which needs the co-factor tetrahydrobiopterin to work. Tyrosine is then used to synthesize various molecules. It is turned into dopamine, which is a neurotransmitter that neurons use to communicate, norepinephrine and epinephrine, which are also neurotransmitters and hormones used by the sympathetic nervous system, and the pigment melanin, which gives color to the skin, hair, and eyes.

Alternatively, when phenylalanine levels in the blood are high, it gets converted by the enzyme phenylalanine transaminase into phenylketones such as phenylpyruvate, phenyllactate, and phenylacetate.

There are three types of Phenylketonuria. Classic, Tetrahydrobiopterin deficient, and maternal. Classic Phenylketonuria, which can be mild or severe, and Tetrahydrobiopterin deficient Phenylketonuria are both autosomal recessive genetic disorders which affect the phenylalanine hydroxylase enzyme.

In the Classic form, there’s a deficiency in the enzyme and individuals with the mild form have a more functional enzyme than those with the severe form so they can tolerate some phenylalanine in their diet.

In the Tetrahydrobiopterin deficient form, the co-factor Tetrahydrobiopterin is deficient and as a result the enzyme can’t work. Without phenylalanine hydroxylase, phenylalanine cannot be converted into tyrosine which causes phenylalanine levels to rise and tyrosine levels to fall. Without tyrosine in the body there’s no melanin so the skin, eyes, and hair lose their color.

Also, it turns out that phenylalanine uses the same transporters to get across the blood brain barrier to other amino acids, tyrosine and tryptophan. Tyrosine is needed to synthesize dopamine and norepinephrine, and tryptophan is needed to synthesize neurotransmitter serotonin. As phenylalanine levels rise, it occupies all the transporters, making it hard for tyrosine and tryptophan to get across the blood brain barrier. As a result, dopamine, norepinephrine, and serotonin levels in the brain all begin to fall, and that leads to problems in brain development and intellectual disability.

In phenylketonuria, lipoproteins which are used to transport fat through blood and cholesterol are also affected. It’s thought that phenylalanine impairs cholesterol synthesis which leads to low levels of cholesterol, both low density lipoproteins (LDLs) and high density lipoproteins (HDLs). These are all important components of myelin which is the outer insulating layer of neurons that helps facilitate rapid impulses. The lack of myelin further contributes to problems with brain development.


Phenylketonuria (PKU) is an autosomal recessive amino acid metabolism disorder involving impaired metabolism of the amino acid phenylalanine, caused by the absence or reduced activity of phenylalanine hydroxylase. In PKU toxic levels of phenylalanine and phenylketone build up in the body and tyrosine levels drop.

Symptoms include a musty odor of sweat and urine, intellectual disability, seizures, behavioral problems, and other neurological symptoms. In pregnant females, PKU can affect the fetus - causing heart disease, growth problems, intellectual disability, and microcephaly. Treatment is based on a diet with low levels of phenylalanine and supplementing with tyrosine and tetrahydrobiopterin.